Browsing by Author "Stulic, Milos (55895099100)"
Now showing 1 - 12 of 12
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication A simple index for nonalcoholic steatohepatitis—HUFA—based on routinely performed blood tests(2019) ;Culafic, Milica (55881915300) ;Kovacevic, Sandra Vezmar (57204567668) ;Dopsaj, Violeta (6507795892) ;Stulic, Milos (55895099100) ;Vlaisavljevic, Zeljko (56461417200) ;Miljkovic, Branislava (6602266729)Culafic, Djordje (6603664463)Background and objectives: Data suggests that nearly 30% of the general population have steatosis and up to 5% of this population develops nonalcoholic steatohepatitis (NASH). Liver biopsy is still considered to be the gold standard for the diagnosis of NASH. Great effort is being made toward the identification of sensitive diagnostic tests that do not involve invasive procedures to address a common concern in patients with the nonalcoholic fatty liver disease—whether they have NASH or simple steatosis. We aimed to investigate the independent predictors and develop a non-invasive, easy-to-perform, low-cost set of parameters that may be used in clinical practice to differentiate simple steatosis from NASH. Methods: A cross-sectional study of nonalcoholic fatty liver disease (NAFLD) patients divided into two groups: group I—simple steatosis (SS) and group II—biopsy-proven NASH. Strict inclusion criteria and stepwise analysis allowed the evaluation of a vast number of measured/estimated parameters. Results: One hundred and eleven patients were included—82 with simple steatosis and 29 with biopsy-proven NASH. The probability of NASH was the highest when homeostatic model assessment of insulin resistance (HOMA-IR) was above 2.5, uric acid above 380 µmol/L, ferritin above 100 µg/L and ALT above 45 U/L. An acronym of using first letters was created and named the HUFA index. This combined model resulted in an area under the receiver operator characteristic curve (AUROC) of 0.94, provided sensitivity, specificity, positive predictive value and a negative predictive value for NASH of 70.3%, 95.1%, 83.1% and 90.0%, respectively. Conclusion: We suggest a simple non-invasive predictive index HUFA that encompasses four easily available parameters (HOMA-IR, uric acid, ferritin and ALT) to identify patients with NASH, which may reduce the need for a liver biopsy on a routine basis in patients with NAFLD. © 2019 by the authors. Licensee MDPI, Basel, Switzerland. - Some of the metrics are blocked by yourconsent settings
Publication Accidental Sewing Pin Ingestion by a Tailor: A Case Report and Literature Review(2023) ;Stojkovic, Stefan (58448712900) ;Bjelakovic, Milica (14029809600) ;Stojkovic Lalosevic, Milica (57218133245) ;Stulic, Milos (55895099100) ;Pejic, Nina (57210712517) ;Radivojevic, Nemanja (57216412671) ;Stojkovic, Nemanja (58618429900) ;Martinov Nestorov, Jelena (16230832200)Culafic, Djordje (6603664463)Foreign body ingestion is a frequently encountered emergency in healthcare institutions. It mostly affects pediatric populations, although it can also affect adults with developmental delays, those with psychiatric diseases, drug abusers, and prisoners. Endoscopy is a diagnostic and treatment method for suspected foreign body ingestion. In this article, we discuss a 45-year-old tailor who swallowed a sewing pin while at work. The abdominal X-ray showed a needle-shaped metal shadow in the stomach region. During an upper endoscopy, it was discovered that a sewing pin with a sharp edge was stuck in the pylorus. The sewing pin was extracted endoscopically, and the patient was discharged the same day in good condition. Since the estimated risk of complications of foreign body ingestion in the adult population is about 35%, and the most common complications include impaction, laceration, bleeding, or perforation of the gastrointestinal wall, endoscopic or surgical removal is necessary. This also emphasizes the importance of a careful endoscopic evaluation of some at-risk occupations for foreign body ingestion with or without gastrointestinal complaints. © 2023 by the authors. - Some of the metrics are blocked by yourconsent settings
Publication Attitudes of Nurses Toward Organ Donation in Serbia(2020) ;Vlaisavljevic, Zeljko (56461417200) ;Jankovic, Slobodan (7101906319) ;Maksimovic, Natasa (12772951900) ;Culafic, Milica (55881915300) ;Stulic, Milos (55895099100) ;Milovanovic, Tamara (55695651200)Oluic, Branislav (57201078229)Objective: Nurses represent the key persons in the process of organ donation, acting as intermediaries between the patient and the family of a potential donor. The aim of this study was to analyze the factors influencing the attitudes of nurses toward bequeathing and organ and tissue donation. Methods: The research was designed as a cross-sectional study from November 2013 to November 2014 and included a sample of 264 nurses employed in the health system of Serbia. Data were collected using a specific questionnaire of 18 questions referring to the information on sociodemographic characteristics and the knowledge of organ donation. Results: The investigation enrolled 264 participants, of which 78% were women. The majority of study subjects had secondary medical education (64.4%), lived in an urban area (82.6%), were married (56.4%), and were predominantly Orthodox (87.1%) with their work experience between 5 and 10 years (29.9%) and 10 to 20 years (29.5%). The average knowledge score concerning organ donation was 29.03 (SD, 2.33; range, 23-34). There was a statistically significant difference in the scores between 2 groups formed according the length of service (P < .001) and the level of education (P = .019), which showed the strongest influence on nurses’ attitudes toward donation. Conclusion: This investigation showed that nurses did not express strong positive attitude toward this issue. Further education of nurses in the Serbian health care system focusing on transplantation and bequeathing of organs and tissues are warranted. © 2020 Elsevier Inc. - Some of the metrics are blocked by yourconsent settings
Publication EncephalApp Stroop Test as a Screening Tool for the Detection of Minimal Hepatic Encephalopathy in Patients with Cirrhosis—Single-Center Experience(2024) ;Vojnovic, Marko (57363900100) ;Pantic, Ivana (57223613349) ;Jankovic, Goran (7005387171) ;Stulic, Milos (55895099100) ;Lalosevic, Milica Stojkovic (57218133245) ;Pejic, Nina (57210712517)Milovanovic, Tamara (55695651200)Background: Minimal hepatic encephalopathy (MHE) is the mildest form of hepatic encephalopathy. One of the neuropsychological tests that detects MHE is the Stroop test (via EncephalApp). The aim was to evaluate the Stroop test for the screening and diagnosis of MHE. Methods: This prospective case–control study was performed at the Clinic for Gastroenterology and Hepatology, University Clinical Center of Serbia, and included patients with cirrhosis and MHE and healthy controls. In all patients, the presence of MHE was confirmed using the animal naming test. The Stroop test was performed on each participant, and the results were compared between the two groups. The test has two components, the “OFF” and “ON” states. Results: A total of 111 participants were included. The median OFF time did not differ between the two groups, 106.3 and 91.4, p > 0.05. However, in patients with MHE, the median values of ON time and total time were significantly higher, with 122.3 vs. 105.3 and 228.0 vs. 195.6, respectively, p < 0.05. Statistical significance between patients and controls in examined parameters was detected in younger participants and the group with higher educational levels. Conclusions: The Stroop test displayed limited sensitivity in Serbian patients. Age and education affect time measurements and test performance. © 2024 by the authors. - Some of the metrics are blocked by yourconsent settings
Publication Evaluating ground glass opacities (GGO) in the COVID-19 era. Do autoantibodies help?(2022) ;Pejic, Nina (57210712517) ;Lalosevic, Milica Stojkovic (57218133245) ;Stulic, Milos (55895099100) ;Culafic, Milica (55881915300)Culafic, Djordje (6603664463)Introduction: COVID-19 is an infectious disease, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and there have been outbreaks worldwide. The presentation may include unspecific and mild symptoms, myalgia, headaches, high fever, dry cough, severe dyspnea and acute respiratory distress syndrome (ARDS). Case study: We present a rare case of microscopic polyangiitis (MPA) with interstitial lung disease and without renal involvement misdiagnosed as COVID-19. Conclusions: Differential diagnosis of COVID-19 is extremely important, and must be correctly identified in order to proceed with correct treatment. Copyright © 2022 Pejic et al. - Some of the metrics are blocked by yourconsent settings
Publication Evaluating ground glass opacities (GGO) in the COVID-19 era. Do autoantibodies help?(2022) ;Pejic, Nina (57210712517) ;Lalosevic, Milica Stojkovic (57218133245) ;Stulic, Milos (55895099100) ;Culafic, Milica (55881915300)Culafic, Djordje (6603664463)Introduction: COVID-19 is an infectious disease, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and there have been outbreaks worldwide. The presentation may include unspecific and mild symptoms, myalgia, headaches, high fever, dry cough, severe dyspnea and acute respiratory distress syndrome (ARDS). Case study: We present a rare case of microscopic polyangiitis (MPA) with interstitial lung disease and without renal involvement misdiagnosed as COVID-19. Conclusions: Differential diagnosis of COVID-19 is extremely important, and must be correctly identified in order to proceed with correct treatment. Copyright © 2022 Pejic et al. - Some of the metrics are blocked by yourconsent settings
Publication Hepcidin is a reliable marker of iron deficiency anemia in newly diagnosed patients with inflammatory bowel disease(2020) ;Lalosevic, Milica Stojkovic (57218133245) ;Toncev, Ljubisa (56023913400) ;Stankovic, Sanja (7005216636) ;Dragasevic, Sanja (56505490700) ;Stojkovic, Stefan (58448712900) ;Jovicic, Ivana (55672227100) ;Stulic, Milos (55895099100) ;Culafic, Djordje (6603664463) ;Milovanovic, Tamara (55695651200) ;Stojanovic, Marija (57218666738) ;Aleksic, Marko (57211851267) ;Stjepanovic, Mihailo (55052044500) ;Lalosevic, Jovan (57190969635) ;Kiurski, Stanimir (57220806455) ;Oluic, Branislav (57201078229) ;Markovic, Aleksandra Pavlovic (24438035400)Stojkovic, Mirjana (58776160500)Background and Aim. Differentiating iron deficiency anemia (IDA) from anemia of chronic disease (ACD) in patients with inflammatory bowel disease (IBD) represents a clinical challenge. Hepcidin is a polypeptide synthetized in the liver, and iron levels or inflammation mostly regulate hepcidin production. Our aim was to determine serum hepcidin levels in patients with inflammatory bowel disease (IBD) as well to investigate whether hepcidin levels correlate with disease activity. Material and Methods. A case-control study was preformed among newly diagnosed IBD patients and same number age- and sex-matched healthy controls. All patients underwent a total ileocolonoscopy. Complete blood count was obtained in addition to inflammatory markers (CRP, erythrocyte sedimentation rate-ESR). Serum levels of hepcidin were determined with commercially available enzyme-linked immunosorbent assay (DRG Instruments Marburg, Germany). Serum iron, TIBC, and UIBC were assessed with an electrochemiluminesence immunoassay, and soluble transferrin receptor (sTfR) was assessed using an immunoturbidimetric method. Mayo score and CDAI, respectively, were calculated for each patient. Statistical analyses were performed using the SPSS software version 20.0 for Windows. Results. There was a high statistically significant difference between IBD patients and controls in levels of hepcidin (P < 0:01). Namely, serum hepcidin levels were significantly higher in the control group. There was no statistically significant correlation of serum hepcidin with CRP, Mayo score, or CDAI, respectively (P > 0:05). However, we have found a statistically significant negative correlation of sTfR and TIBC with hepcidin (P < 0:01). Conclusion. Results of our study suggest that hepcidin is a reliable marker of IDA in patients with IBD, and it could be used in routine clinical practice when determining adequate therapy in these patients. Copyright © 2020 Stojkovic Lalosevic Milica et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - Some of the metrics are blocked by yourconsent settings
Publication Hepcidin is a reliable marker of iron deficiency anemia in newly diagnosed patients with inflammatory bowel disease(2020) ;Lalosevic, Milica Stojkovic (57218133245) ;Toncev, Ljubisa (56023913400) ;Stankovic, Sanja (7005216636) ;Dragasevic, Sanja (56505490700) ;Stojkovic, Stefan (58448712900) ;Jovicic, Ivana (55672227100) ;Stulic, Milos (55895099100) ;Culafic, Djordje (6603664463) ;Milovanovic, Tamara (55695651200) ;Stojanovic, Marija (57218666738) ;Aleksic, Marko (57211851267) ;Stjepanovic, Mihailo (55052044500) ;Lalosevic, Jovan (57190969635) ;Kiurski, Stanimir (57220806455) ;Oluic, Branislav (57201078229) ;Markovic, Aleksandra Pavlovic (24438035400)Stojkovic, Mirjana (58776160500)Background and Aim. Differentiating iron deficiency anemia (IDA) from anemia of chronic disease (ACD) in patients with inflammatory bowel disease (IBD) represents a clinical challenge. Hepcidin is a polypeptide synthetized in the liver, and iron levels or inflammation mostly regulate hepcidin production. Our aim was to determine serum hepcidin levels in patients with inflammatory bowel disease (IBD) as well to investigate whether hepcidin levels correlate with disease activity. Material and Methods. A case-control study was preformed among newly diagnosed IBD patients and same number age- and sex-matched healthy controls. All patients underwent a total ileocolonoscopy. Complete blood count was obtained in addition to inflammatory markers (CRP, erythrocyte sedimentation rate-ESR). Serum levels of hepcidin were determined with commercially available enzyme-linked immunosorbent assay (DRG Instruments Marburg, Germany). Serum iron, TIBC, and UIBC were assessed with an electrochemiluminesence immunoassay, and soluble transferrin receptor (sTfR) was assessed using an immunoturbidimetric method. Mayo score and CDAI, respectively, were calculated for each patient. Statistical analyses were performed using the SPSS software version 20.0 for Windows. Results. There was a high statistically significant difference between IBD patients and controls in levels of hepcidin (P < 0:01). Namely, serum hepcidin levels were significantly higher in the control group. There was no statistically significant correlation of serum hepcidin with CRP, Mayo score, or CDAI, respectively (P > 0:05). However, we have found a statistically significant negative correlation of sTfR and TIBC with hepcidin (P < 0:01). Conclusion. Results of our study suggest that hepcidin is a reliable marker of IDA in patients with IBD, and it could be used in routine clinical practice when determining adequate therapy in these patients. Copyright © 2020 Stojkovic Lalosevic Milica et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - Some of the metrics are blocked by yourconsent settings
Publication Intrahepatic cholestasis of pregnancy: A case study of the rare onset in the first trimester(2019) ;Stulic, Milos (55895099100) ;Culafic, Djordje (6603664463) ;Boricic, Ivan (6603959716) ;Lalosevic, Milica Stojkovic (57218133245) ;Pejic, Nina (57210712517) ;Jankovic, Goran (7005387171) ;Milovanovic, Tamara (55695651200) ;Culafic-Vojinovic, Violeta (16686529100) ;Vlaisavljevic, Zeljko (56461417200)Culafic, Milica (55881915300)Intrahepatic cholestasis of pregnancy (ICP) is a gestation-specific liver disorder, defined most often as the onset of pruritus, usually from the third trimester of pregnancy, associated with abnormal liver test results and/or increased total serum bile acids and spontaneous relief after delivery. The 21-year-old patient was admitted to our ward in the 11th week of pregnancy due to raised liver enzymes. The first onset of pruritus and jaundice appeared a month before hospitalization. Immunology tests and Toxoplasma gondii were negative. We excluded viral etiology, while alpha-1-antitrypsin, serum and urine copper levels, and thyroid hormones were within the reference values. The patient denied she had taken any medicines and herbal preparations before and during pregnancy. Total bile acids in the serum were significantly elevated (242 µmol/L). The abdominal ultrasound revealed a regular finding. Liver biopsy suggested a cholestatic liver disorder. After a presentation of all risks, the patient decided to stop the pregnancy. After a month, the hepatogram was within the reference values. Very rarely an ICP can occur in early pregnancy (first trimester), which calls for close monitoring. The risk of serious adverse fetal outcomes and spontaneous preterm delivery is proportional with increased levels of maternal serum bile acid. © 2019 by the authors. Licensee MDPI, Basel, Switzerland. - Some of the metrics are blocked by yourconsent settings
Publication Perineural invasion as a prognostic factor in patients with stage I-III rectal cancer-5-year follow up(2020) ;Lalosevic, Milica Stojkovic (57218133245) ;Milovanovic, Tamara (55695651200) ;Micev, Marjan (7003864533) ;Stojkovic, Mirjana (58776160500) ;Dragasevic, Sanja (56505490700) ;Stulic, Milos (55895099100) ;Rankovic, Ivan (57192091879) ;Dugalic, Vladimir (9433624700) ;Krivokapic, Zoran (55503352000)Markovic, Aleksandra Pavlovic (24438035400)BACKGROUND Rectal cancer (RC) is one of the most common diagnosed cancers, and one of the major causes of cancer-related death nowadays. Majority of the current guidelines rely on TNM classification regarding therapy regiments, however recent studies suggest that additional histopathological findings could affect the disease course. AIM To determine whether perineural invasion alone or in combination with lymphovascular invasion have an effect on 5-years overall survival (OS) of RC patients. METHODS A prospective study included newly diagnosed stage I-III RC patients treated and followed at the Digestive Surgery Clinic, Clinical Center of Serbia, between the years of 2014-2016. All patients had their diagnosis histologically confirmed in accordance with both TMN and Dukes classification. In addition, the patient's demographics, surgical details, postoperative pathological details, differentiation degree and their correlation with OS was investigated. RESULTS Of 245 included patients with stage I-III RC, lymphovascular invasion (LVI) was identified in 92 patients (38%), whereas perineural invasion (PNI) was present in 46 patients (19%). Using Kaplan-Meier analysis for overall survival rate, we have found that both LVI and PNI were associated with lower survival rates (P < 0.01). Moreover when Cox multiple regression model was used, LVI, PNI, older age, male gender were predictors of poor prognosis (HR = 5.49; 95%CI: 2.889-10.429; P < 0.05). CONCLUSION LVI and PNI were significant factors predicting worse prognosis in early and intermediate RC patients, hence more aggressive therapy should be reserved for these patients after curative resection. © 2020, Baishideng Publishing Group Co. - Some of the metrics are blocked by yourconsent settings
Publication The clinical importance of cystatin C and hepatic artery resistive index in liver cirrhosis(2018) ;Stulic, Milos (55895099100) ;Culafic, Djordje (6603664463) ;Obrenovic, Radmila (56199010700) ;Jankovic, Goran (7005387171) ;Alempijevic, Tamara (15126707900) ;Lalosevic, Milica Stojkovic (57218133245) ;Dostanic, Natasa (57203871434) ;Kovacevic, Sandra Vezmar (57204567668)Culafic, Milica (55881915300)Background: Data suggest cystatin C (CysC) levels and hepatic artery resistive index (HARI) correspond to the progression of chronic liver disease. We aimed to evaluate the clinical significance of these parameters in assessment of fibrosis in patients with liver cirrhosis. Methods: The cross-sectional study included 63 patients with liver cirrhosis. A control group consisted of 30 age-and gender-matched healthy persons. Results: We confirmed significantly higher values of CysC in patients with cirrhosis compared to control group (p = 0.036). Average value of HARI in the examined group was increased (0.72 ± 0.06) and there was the statistically significant difference compared to controls (0.66 ± 0.03) (p < 0.001). We found statistically significant correlation between HARI and CysC in the study group. Analyzing the possibility of distinguishing healthy subjects from patients with fibrosis, we have found that the area under the curve is far greater in the HARI index than CysC. Comparison of CysC among Child–Pugh stages and correlation with a model for end-stage liver disease (MELD) score showed statistically significant results. Conclusion: We confirmed HARI is a more accurate parameter than CysC in discriminating healthy subjects from patients with fibrosis, while CysC could be a better indicator of the stage of liver cirrhosis. © 2018 by the authors. Licensee MDPI, Basel, Switzerland. - Some of the metrics are blocked by yourconsent settings
Publication West Nile Virus Infection in Liver Transplant Recipient With Neither De Novo Infection nor Donor-Derived Infection: A Case Report(2023) ;Stulic, Milos (55895099100) ;Culafic, Djordje (6603664463) ;Jordovic, Jelena (57190498051) ;Culafic, Milica (55881915300) ;Petrovic, Natasa (57095580700) ;Stojimirov, Ivan (58096517000)Loncar, Zlatibor (26426476500)West Nile virus was first described in 1937 and has since periodically appeared in various parts of the world by infecting people and horses. Reported infection symptoms and signs may be highly variable, ranging from fever and myalgias to meningoencephalitis. A 59-year-old patient was admitted to the University Clinical Centre of Serbia, Belgrade, in September 2018, where liver transplant was performed to treat cirrhosis of ethyl etiology. Immunosuppressive therapy was started immediately after successful transplant, with the patient receiving methylprednisolone, tacrolimus, and mycophenolate mofetil. Mycophenolate mofetil was excluded from therapy on postoperative day 3 because of progressively worse white blood cell count. The patient became febrile on postoperative day 11 (39.6 °C), and arm tremor, nausea, vomiting, and frequent fluid stools occurred. He complained of pain in the muscles and joints of the lower extremities. The next day he experienced occasional disorientation. Neurological findings revealed no signs of acute focal neurological deficit. We performed culture tests to isolate pathological microorganisms, and results were negative in cultures of the blood, urine, feces, ascites, and a smear of the wound and tip of the central venous catheter. Lumbar puncture resulted in a clear cerebrospinal fluid that was sent for analysis that showed significant increases in white blood cell count (94 × 106 cells/L), total proteins (1.61 g/L), and microalbumin (504.5 mg/L), with a reduction of immunoglobulin G. On postoperative day 15, positive serology of West Nile virus immunoglobulin M in cerebrospinal fluid was verified. Intensive monitoring and symptomatic and supportive therapy resulted in clinical and laboratory improvement, and the patient was discharged in good general condition on postoperative day 22. Considering the high risk of posttransplant complications, there remains the question of whether all donors and recipients should be tested for West Nile virus at the onset of transplant. © Başkent University 2023.
